Following recent forced divestments - and with growing political concern about life sciences acquisitions - the signs are that regulators will play a larger role in transactions
Read more
The company has surpassed other healthcare powerhouses and kept Apple and Alphabet at bay, but a robust portfolio does not guarantee smooth sailing
Read more
The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference
Read more
Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications
Read more
As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate
Read more
Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean
Read more
After deal for cellular chip business with Apple, the company places rest of the assets that were on the market in the summer back on the auction block
Read more
IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value
Read more
Portfolio analysis shows there is no clear leader right now, but Microsoft, IBM, Intel and Northrop Grumman are among those vying for top spot
Read more
The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling
Read more
Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases
Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
